Mohanta SK, Peng L, Li Y et al (2022) Neuroimmune cardiovascular interfaces control atherosclerosis. Nature 605:152–159

Article  CAS  PubMed  Google Scholar 

Stone PH, Libby P, Boden WE (2023) Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis: a narrative review. JAMA Cardiol 8:192–201

Article  PubMed  PubMed Central  Google Scholar 

Tufaro V, Serruys PW, Räber L et al (2023) Intravascular imaging assessment of pharmacotherapies targeting atherosclerosis: advantages and limitations in predicting their prognostic implications. Cardiovasc Res 119:121–135

Article  CAS  PubMed  Google Scholar 

Achenbach S, Fuchs F, Goncalves A et al (2022) Non-invasive imaging as the cornerstone of cardiovascular precision medicine. Eur Heart J Cardiovasc Imaging 23:465–475

Article  PubMed  Google Scholar 

Derlin T, Werner RA, Weiberg D, Derlin K, Bengel FM (2022) Parametric imaging of biologic activity of atherosclerosis using dynamic whole-body positron emission tomography. JACC Cardiovasc Imaging 15:2098–2108

Article  PubMed  Google Scholar 

Feil S, Stowbur D, Schörg BF et al (2023) Noninvasive detection of smooth muscle cell-derived hot spots to study atherosclerosis by PET/MRI in mice. Circ Res 132:747–750

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Velzen SGM, Dobrolinska MM, Knaapen P et al (2023) Automated cardiovascular risk categorization through AI-driven coronary calcium quantification in cardiac PET acquired attenuation correction CT. J Nucl Cardiol 30:955–969

Article  PubMed  Google Scholar 

Zan C, An J, Wu Z, Li S (2023) Engineering molecular nanoprobes to target early atherosclerosis: precise diagnostic tools and promising therapeutic carriers. Nanotheranostics 7:327–344

Article  PubMed  PubMed Central  Google Scholar 

Blach A, Kwiecinski J (2023) The role of positron emission tomography in advancing the understanding of the pathogenesis of heart and vascular diseases. Diagnostics (Basel) 13:1791

Article  CAS  PubMed  Google Scholar 

Bucerius J, Dijkgraaf I, Mottaghy FM, Schurgers LJ (2019) Target identification for the diagnosis and intervention of vulnerable atherosclerotic plaques beyond 18F-fluorodeoxyglucose positron emission tomography imaging: promising tracers on the horizon. Eur J Nucl Med Mol Imaging 46:251–265

Article  PubMed  Google Scholar 

Fu Z, Lin Q, Xu Z et al (2022) P2X7 receptor-specific radioligand 18F-FTTM for atherosclerotic plaque PET imaging. Eur J Nucl Med Mol Imaging 49:2595–2604

Article  CAS  PubMed  Google Scholar 

Maekawa K, Tsuji AB, Yamashita A et al (2021) Translocator protein imaging with 18F-FEDAC-positron emission tomography in rabbit atherosclerosis and its presence in human coronary vulnerable plaques. Atherosclerosis 337:7–17

Article  CAS  PubMed  Google Scholar 

Stein S, Weber J, Nusser-Stein S et al (2021) Deletion of fibroblast activation protein provides atheroprotection. Cardiovasc Res 117:1060–1069

Article  CAS  PubMed  Google Scholar 

Kosmala A, Serfling SE, Michalski K et al (2023) Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors. Eur J Nucl Med Mol Imaging 50:3011–3021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wei Y, Zheng J, Ma L et al (2022) [18F]AlF-NOTA-FAPI-04: FAP-targeting specificity, biodistribution, and PET/CT imaging of various cancers. Eur J Nucl Med Mol Imaging 49:2761–2773

Article  CAS  PubMed  Google Scholar 

Wang S, Zhou X, Xu X et al (2021) Clinical translational evaluation of Al18F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging. Eur J Nucl Med Mol Imaging 48:4259–4271

Article  CAS  PubMed  Google Scholar 

Gong JN, Chen BX, Xing HQ, Huo L, Yang YH, Yang MF (2023) Pulmonary artery imaging with 68 Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension. J Nucl Cardiol 30:1166–1172

Article  PubMed  Google Scholar 

Wu M, Ning J, Li J et al (2022) Feasibility of in vivo imaging of fibroblast activation protein in human arterial walls. J Nucl Med 63:948–951

Article  CAS  PubMed  PubMed Central  Google Scholar 

Izquierdo-Garcia D, Diyabalanage H, Ramsay IA et al (2022) Imaging high-risk atherothrombosis using a novel fibrin-binding positron emission tomography probe. Stroke 53:595–604

Article  CAS  PubMed  Google Scholar 

Huang Z, Cheng XQ, Liu HY et al (2022) Relation of carotid plaque features detected with ultrasonography-based radiomics to clinical symptoms. Transl Stroke Res 13:970–982

Article  PubMed  Google Scholar 

Zhang J, Lin Z, Zhang X et al (2022) 68Ga-DOTA-DiPSMA PET/CT imaging: biodistribution, dosimetry, and preliminary application in prostate cancer. Front Bioeng Biotechnol 9:811972

Article  PubMed  PubMed Central  Google Scholar 

Yruela I, Oldfield CJ, Niklas KJ, Dunker AK (2017) Evidence for a strong correlation between transcription factor protein disorder and organismic complexity. Genome Biol Evol 9:1248–1265

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kafouris PP, Koutagiar IP, Georgakopoulos AT, Spyrou GM, Visvikis D, Anagnostopoulos CD (2021) Fluorine-18 fluorodeoxyglucose positron emission tomography-based textural features for prediction of event prone carotid atherosclerotic plaques. J Nucl Cardiol 28:1861–1871

Article  PubMed  Google Scholar 

Brokopp CE, Schoenauer R, Richards P et al (2011) Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur Heart J 32:2713–2722

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piri R, Lici G, Riyahimanesh P, Gerke O, Alavi A, Høilund-Carlsen PF (2021) Two-year change in 18F-sodium fluoride uptake in major arteries of healthy subjects and angina pectoris patients. Int J Cardiovasc Imaging 37:3115–3126

Article  PubMed  Google Scholar 

Bacour YAA, van Kanten MP, Smit F et al (2023) Development of a simple standardized scoring system for assessing large vessel vasculitis by 18F-FDG PET-CT and differentiation from atherosclerosis. Eur J Nucl Med Mol Imaging 50:2647–2655

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patel NH, Osborne MT, Teague H et al (2021) Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: an observational study. Atherosclerosis 339:20–26

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kitagawa T, Nakano Y (2022) Innovative atherosclerosis imaging using 18F-NaF PET/CT: Its clinical potential. J Nucl Cardiol 29:1724–1728

Article  PubMed  Google Scholar 

Oliveira-Santos M, Castelo-Branco M, Silva R et al (2017) Atherosclerotic plaque metabolism in high cardiovascular risk subjects - a subclinical atherosclerosis imaging study with 18F-NaF PET-CT. Atherosclerosis 260:41–46

Article  PubMed  Google Scholar 

Kircher M, Tran-Gia J, Kemmer L et al (2020) Imaging Inflammation in Atherosclerosis with CXCR4-Directed 68Ga-Pentixafor PET/CT: correlation with 18F-FDG PET/CT. J Nucl Med 61:751–756

Article  CAS  PubMed  Google Scholar 

Weiberg D, Thackeray JT, Daum G et al (2018) Clinical molecular imaging of chemokine receptor CXCR4 expression in atherosclerotic plaque using 68Ga-pentixafor PET: correlation with cardiovascular risk factors and calcified plaque burden. J Nucl Med 59:266–272

Article  CAS  PubMed  Google Scholar 

Li X, Heber D, Leike T et al (2018) [68Ga]Pentixafor-PET/MRI for the detection of Chemokine receptor 4 expression in atherosclerotic plaques. Eur J Nucl Med Mol Imaging 45:558–566

Article  CAS  PubMed  Google Scholar 

Qi N, Wang H, Wang H et al (2022) Non-tumoral uptake of 68Ga-FAPI-04 PET: a retrospective study. Front Oncol 12:989595

Article  CAS  PubMed  PubMed Central  Google Scholar 

Francque SM, van der Graaff D, Kwanten WJ (2016) Non-alcoholic fatty liver disease and cardiovascular risk: pathophysiological mechanisms and implications. J Hepatol 65:425–443

Article  CAS  PubMed  Google Scholar 

Emrich T, Schattenberg JM (2021) Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing. Aliment Pharmacol Ther 54:214–215

Article  PubMed  Google Scholar 

Park JG, Jung J, Verma KK et al (2021) Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 53:1030–1037

Article  PubMed  PubMed Central